Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety and PK Study of CU06-1004 in Healthy Subjects
NCT04795037Phase 1Completed
- Sponsor
- Curacle Co., Ltd.
- Start
- Jul 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of CU06-RE in diabetic macular edema (DME) (4 arms), sponsored by Curacle Co., Ltd. Primary endpoint: Treatment Emergent Adverse Events. Started Jul 2021; status: completed.
02
Drugs
CU06-RE
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04795037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04795037.